We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$103M
Cap. Flow %
4.35%
Top 10 Hldgs %
34.74%
Holding
3,215
New
293
Increased
1,348
Reduced
581
Closed
158
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
1.9 years
Top 20 Avg Time Held Equity + Options
2.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
2.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.15%
2 Technology 15.95%
3 Financials 7.59%
4 Healthcare 5.97%
5 Communication Services 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VRP icon
2501
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$3K ﹤0.01%
111
– –
2020 Q4
2 quarters
VSH icon
2502
Vishay Intertechnology
VSH
$4.41B
$3K ﹤0.01%
140
-23
-14% -$552
2016 Q4
18 quarters
VTVT icon
2503
vTv Therapeutics
VTVT
$109M
$3K ﹤0.01%
38
– –
2020 Q2
4 quarters
WD icon
2504
Walker & Dunlop
WD
$1.14B
$3K ﹤0.01%
32
– –
2018 Q3
11 quarters
XRX icon
2505
Xerox
XRX
$352M
$3K ﹤0.01%
109
+61
+127% +$1.48K
2016 Q4
18 quarters
YYY icon
2506
Amplify CEF High Income ETF
YYY
$654M
$3K ﹤0.01%
145
– –
2020 Q2
4 quarters
NEUE icon
2507
DELISTED
NeueHealth
NEUE
$3K ﹤0.01%
+3
New +$4.11K
2021 Q2
0 quarters
TBCH icon
2508
Turtle Beach Corp
TBCH
$290M
$3K ﹤0.01%
102
– –
2020 Q4
2 quarters
CDMO icon
2509
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3K ﹤0.01%
+110
New +$2.35K
2021 Q2
0 quarters
TARO icon
2510
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$3K ﹤0.01%
38
– –
2019 Q3
7 quarters
BTWN
2511
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$3K ﹤0.01%
300
-427
-59% -$4.43K
2020 Q4
2 quarters
MNTV
2512
DELISTED
Momentive Global Inc. Common Stock
MNTV
$3K ﹤0.01%
123
– –
2019 Q2
8 quarters
FEO
2513
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$3K ﹤0.01%
203
– –
2021 Q1
1 quarter
SRSA
2514
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$3K ﹤0.01%
300
– –
2021 Q1
1 quarter
MNR icon
2515
DELISTED
Monmouth Real Estate Investment Corp
MNR
$3K ﹤0.01%
+138
New +$2.59K
2021 Q2
0 quarters
ABUS icon
2516
Arbutus Biopharma
ABUS
$850M
$2K ﹤0.01%
550
– –
2020 Q3
3 quarters
ACRS icon
2517
Aclaris Therapeutics
ACRS
$514M
$2K ﹤0.01%
100
-1,100
-92% -$25K
2018 Q3
11 quarters
ADEA icon
2518
Adeia
ADEA
$2.4B
$2K ﹤0.01%
291
– –
2017 Q2
16 quarters
AG icon
2519
First Majestic Silver
AG
$7.93B
$2K ﹤0.01%
115
-267
-70% -$4.45K
2020 Q3
3 quarters
AGEN icon
2520
Agenus
AGEN
$302M
$2K ﹤0.01%
21
– –
2018 Q3
11 quarters
AMWD icon
2521
DELISTED
American Woodmark
AMWD
$2K ﹤0.01%
26
– –
2020 Q1
5 quarters
API icon
2522
Agora
API
$365M
$2K ﹤0.01%
50
– –
2021 Q1
1 quarter
ASMB icon
2523
Assembly Biosciences
ASMB
$419M
$2K ﹤0.01%
+40
New +$1.98K
2021 Q2
0 quarters
ATEX icon
2524
Anterix
ATEX
$1.66B
$2K ﹤0.01%
37
– –
2020 Q2
4 quarters
AUB icon
2525
Atlantic Union Bankshares
AUB
$5.47B
$2K ﹤0.01%
56
-12
-18% -$471
2020 Q1
5 quarters

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $103M of net new capital in Q2 2021, opening 293 new positions and adding to 1,348 existing holdings. Its largest new stake was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 293 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.